buserelin has been researched along with Hyperplasia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barraza-Vázquez, A; Fernández-González, EM; Mayagoitia, SB; Vega, MG; Vega, RR | 1 |
Fujibayashi, S; Hamada, H; Ishii, A; Ishizuka, B; Kuribayashi, Y; Ohno, Y; Saito, K; Someya, K; Watanabe, K | 1 |
Höfler, H; Lax, S; Pummer, K; Radner, H; Wandschneider, G | 1 |
1 trial(s) available for buserelin and Hyperplasia
Article | Year |
---|---|
GnRH agonist for postpartum contraception: biochemical, hormonal and endometrial effects.
Topics: Administration, Intranasal; Alanine Transaminase; Bone and Bones; Breast Feeding; Buserelin; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hyperplasia; Lactation; Lipids; Luteinizing Hormone; Menstruation Disturbances; Postpartum Period; Progesterone | 1996 |
2 other study(ies) available for buserelin and Hyperplasia
Article | Year |
---|---|
[A case of significant, non-neoplastic, ovarian hypertestosteronism].
Topics: Adult; Buserelin; Estrogens; Female; Humans; Hyperplasia; Ovarian Diseases; Ovary; Progesterone; Testosterone | 1992 |
Pituitary hyperplasia after goserelin (LHRH-analogue) therapy.
Topics: Adrenocorticotropic Hormone; Aged; Buserelin; Goserelin; Growth Hormone; Humans; Hyperplasia; Immunohistochemistry; Male; Neoplasm Metastasis; Orchiectomy; Pituitary Gland, Anterior; Prostatic Neoplasms | 1991 |